IGF-1 peptide vial
📈 Growth Hormone

IGF-1

Insulin-like Growth Factor-1

Also called IGF-1, insulin-like growth factor 1, somatomedin C, mecasermin

The hormone GH actually works through

IGF-1 is the hormone that does most of growth hormone's work. Growth hormone tells the liver to make IGF-1, and IGF-1 tells muscle and other tissue to grow. As mecasermin (Increlex) it is approved for children with severe primary IGF-1 deficiency; other uses are not approved, and its main risk is low blood sugar.

The main mediator of growth hormone's effects. Most of what growth hormone does to muscle, tissue and growth is carried out by IGF-1, produced mainly in the liver. Most IGF-1 circulates bound to carrier proteins. As mecasermin (Increlex) it is an approved prescription drug for children with severe primary IGF-1 deficiency.

Half-life
Minutes when unbound; hours when carried by binding proteins
Route studied
Subcutaneous injection (Increlex label)
Status
Prescription as mecasermin (Increlex), for severe primary IGF-1 deficiency in children
Moderate Evidence

Studied in people, and well studied in preclinical models

What IGF-1 has been studied for

The reasons people look it up, roughly in order of how often, and what research exists for each. Interest in a use is not evidence that it works; the evidence is stated under each one.

Muscle growth
The main reason people look it up. It signals muscle cells to grow and to take up nutrients. No trial has tested it for muscle growth in healthy adults.
Recovery from training
Discussed on the theory that it speeds repair between training sessions. Not tested for this.
Severe primary IGF-1 deficiency in children
The approved use, as mecasermin (Increlex), for children whose bodies make growth hormone but cannot respond to it normally.

Mechanism of Action

How IGF-1 works

IGF-1 is the downstream effector of the growth hormone axis:

  • IGF-1 receptor (IGF1R) activation. It binds IGF1R and triggers the PI3K/Akt/mTOR pathway that drives protein synthesis, cell growth and repair.
  • Growth-hormone-dependent production. Growth hormone signals the liver to produce IGF-1, so most of growth hormone's effect on tissue is really IGF-1's.
  • Binding proteins. Native IGF-1 is mostly bound to IGFBP-3, with only a small free, active fraction, unlike the engineered LR3 analogue.
  • Shared insulin signalling. IGF1R overlaps with insulin signalling, which is why IGF-1 lowers blood glucose.

IGF-1 side effects: what studies reported

The side-effect profile is well described from the approved drug. IGF-1 acts on machinery shared with insulin, so it lowers blood sugar.

Most commonly reported

  • Low blood sugar: shakiness, sweating, sudden hunger, light-headedness
  • Injection-site reactions
  • Water retention and puffiness
  • Aching joints

Worth keeping an eye on

  • Numbness or tingling in the hands, from swelling pressing on the nerve at the wrist
  • Headaches
  • Jaw and facial aching

The one to take seriously

  • Blood sugar can fall far enough to be dangerous, which is why the Increlex label ties each dose to a meal
  • IGF-1 is a growth signal, and the label contraindicates it in active or suspected cancer

Dose-related findings. Hypoglycaemia is dose-related on the label.

Source: The mecasermin (Increlex) label and clinical experience, plus reports outside trials. This is a summary of published findings, not a complete safety profile and not medical advice. Questions about IGF-1 belong with a licensed clinician who knows your history.

Your Genetics & IGF-1

The genes involved in how IGF-1 works

IGF-1 works through the receptors these genes build, and the genes vary from person to person. Researchers have linked some of that variation to differences in how people respond. A DNA report tells you which versions you carry.

IGF1IGF-1 promoter expression

This promoter variant has been associated with differences in baseline IGF-1 levels in population studies. It describes a baseline, not a response to IGF-1 given as a drug.

Chromosome 15IGF-1 receptor sensitivity

IGF1R · ••

Builds the IGF-1 receptor. Variants have been studied for their association with IGF-1 levels, height and longevity. Not studied as a predictor of response to IGF-1.

Chromosome 7IGF binding-protein capacity

IGFBP3 · ••

The -202 A/C variant has been associated with differences in IGFBP-3, the main IGF-1 carrier protein, in population studies. Pathway context only.

Chromosome 5Growth hormone receptor (d3/fl)

GHR · ••

The exon 3 deletion produces a shorter growth hormone receptor that some studies associated with greater growth hormone sensitivity, upstream of IGF-1 production. Pathway context only.

The dots after each gene are where your own result goes. Your report fills them in with the two letters you carry at that position.

Which of these variants do you carry?

Your report reads the DNA file you already have against this research.

Read my DNA, $99

Often discussed alongside

Compounds that come up next to IGF-1 in research and discussion. Each has its own page. None of this is a suggestion to combine them.

IGF-1

an engineered long-acting versionModerate Evidence

Insulin-like Growth Factor-1

The main mediator of growth hormone's effects. Most of what growth hormone does to muscle, tissue and growth is carried out by IGF-1, produced mainly in the liver. Most IGF-1 circulates bound to carrier proteins. As mecasermin (Increlex) it is an approved prescription drug for children with severe primary IGF-1 deficiency.

4

Gene variants

45+

Studies

Access

Access and legal status

IGF-1: Prescription as mecasermin (Increlex), for severe primary IGF-1 deficiency in children. Decisions about any prescription medicine belong to a prescriber. We don't link to any seller, and nothing on this page is a recommendation to obtain or use it.

Your DNA and IGF-1: see which of the variants studied alongside it you carry, and what that research does and does not show. Read my DNA, $99 →

Educational information only, not medical advice. Most peptides are not FDA-approved. Do not start, stop or change any medication or peptide because of this page; talk to a licensed clinician.

Worth knowing about IGF-1

Interactions and situations where there is a specific reason to be careful. Where the honest answer is that nobody has studied something, it says so and says what that leaves open.

Hypoglycaemia is the main risk
The Increlex label requires each dose to be given with a meal or snack because of the blood-sugar drop. Severe hypoglycaemia is a medical emergency.
It is a growth signal, and growth is not selective
It does not only tell muscle to grow. That is the reason for the cancer caution, and it is not a theoretical one.

Last updated

Frequently Asked Questions

What is the difference between IGF-1 and IGF-1 LR3?

Native IGF-1 is the body's own hormone, mostly bound to carrier proteins, with a short-lived free fraction. IGF-1 LR3 is an engineered analogue that resists those binding proteins and stays active for hours. Both act on the same IGF-1 receptor; the difference is duration and the free fraction.

Why is IGF-1 tied so closely to growth hormone?

Growth hormone exerts most of its tissue effects indirectly, by telling the liver to produce IGF-1. That is why an IGF-1 blood test is used as a practical readout of growth hormone activity.

Do genes affect IGF-1?

Variants in IGF1, IGF1R, IGFBP3 and GHR have been associated with differences in baseline IGF-1 levels in population studies. No study has tested whether they change response to IGF-1 given as a drug. A DNA report can show which versions you carry and what that research does and does not show.

Learn more about IGF-1

11 guides mention IGF-1→

Your DNA and IGF-1

What the research says about your variants.

The report

Which IGF-1 variants do you carry?

Your report reads the DNA file you already have against the published research on 31 peptides, marker by marker, and says what that research does and does not show.

Read my DNA, $99
Upload your DNA